Suppr超能文献

老年样本中的年龄、血管健康与阿尔茨海默病生物标志物

Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.

作者信息

Vemuri Prashanthi, Lesnick Timothy G, Przybelski Scott A, Knopman David S, Lowe Val J, Graff-Radford Jonathan, Roberts Rosebud O, Mielke Michelle M, Machulda Mary M, Petersen Ronald C, Jack Clifford R

机构信息

Department of Radiology, Mayo Clinic, Rochester, MN.

Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

出版信息

Ann Neurol. 2017 Nov;82(5):706-718. doi: 10.1002/ana.25071. Epub 2017 Oct 26.

Abstract

OBJECTIVE

To investigate the associations between age, vascular health, and Alzheimer disease (AD) imaging biomarkers in an elderly sample.

METHODS

We identified 430 individuals along the cognitive continuum aged >60 years with amyloid positron emission tomography (PET), tau PET, and magnetic resonance imaging (MRI) scans from the population-based Mayo Clinic Study of Aging. A subset of 329 individuals had fluorodeoxyglucose (FDG) PET. We ascertained presently existing cardiovascular and metabolic conditions (CMC) from health care records and used the summation of presence/absence of hypertension, hyperlipidemia, cardiac arrhythmias, coronary artery disease, congestive heart failure, diabetes mellitus, and stroke as a surrogate for vascular health. We used global amyloid from Pittsburgh compound B PET, entorhinal cortex tau uptake (ERC-tau) from tau-PET, and neurodegeneration in AD signature regions from MRI and FDG-PET as surrogates for AD pathophysiology. We dichotomized participants into CMC = 0 (CMC ) versus CMC > 0 (CMC ) and tested for age-adjusted group differences in AD biomarkers. Using structural equation models (SEMs), we assessed the impact of vascular health on AD biomarker cascade (amyloid leads to tau leads to neurodegeneration) after considering the direct and indirect age, sex, and apolipoprotein E effects.

RESULTS

CMC participants had significantly greater neurodegeneration than CMC participants but did not differ by amyloid or ERC-tau. The SEMs showed that (1) vascular health had a significant direct and indirect impact on neurodegeneration but not on amyloid; and (2) vascular health, specifically the presence of hyperlipidemia, had a significant direct impact on ERC-tau.

INTERPRETATION

Vascular health had quantifiably greater impact on neurodegeneration in AD regions than on amyloid deposition. Longitudinal studies are warranted to clarify the relationship between tau deposition and vascular health. Ann Neurol 2017;82:706-718.

摘要

目的

在一个老年样本中研究年龄、血管健康与阿尔茨海默病(AD)影像生物标志物之间的关联。

方法

我们从基于人群的梅奥诊所衰老研究中识别出430名年龄大于60岁、处于认知连续体状态的个体,他们接受了淀粉样蛋白正电子发射断层扫描(PET)、tau PET和磁共振成像(MRI)扫描。其中329名个体进行了氟脱氧葡萄糖(FDG)PET检查。我们从医疗记录中确定目前存在的心血管和代谢疾病(CMC),并将高血压、高脂血症、心律失常、冠状动脉疾病、充血性心力衰竭、糖尿病和中风的存在与否进行汇总,以此作为血管健康的替代指标。我们将匹兹堡化合物B PET的全脑淀粉样蛋白、tau - PET的内嗅皮质tau摄取量(ERC - tau)以及MRI和FDG - PET中AD特征区域的神经退行性变作为AD病理生理学的替代指标。我们将参与者分为CMC = 0(无CMC)和CMC > 0(有CMC)两组,并测试AD生物标志物在年龄调整后的组间差异。使用结构方程模型(SEM),我们在考虑年龄、性别和载脂蛋白E的直接和间接影响后,评估血管健康对AD生物标志物级联反应(淀粉样蛋白导致tau蛋白导致神经退行性变)的影响。

结果

有CMC的参与者比无CMC的参与者有更显著的神经退行性变,但在淀粉样蛋白或ERC - tau方面无差异。结构方程模型显示:(1)血管健康对神经退行性变有显著的直接和间接影响,但对淀粉样蛋白无影响;(2)血管健康,特别是高脂血症的存在,对ERC - tau有显著的直接影响。

解读

血管健康对AD区域神经退行性变的影响在数量上大于对淀粉样蛋白沉积的影响。有必要进行纵向研究以阐明tau蛋白沉积与血管健康之间的关系。《神经病学纪事》2017年;82:706 - 718。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/5696029/1526b357307f/nihms911269f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验